Companies Directory

L'Intelligence Artificielle qui génère vos devis en 30 secondes

Neuralink Group

Practical Artificial Intelligence through research.

Neuralle is a talent-first agency, growing attention for creators & consumer brands.

NeuralTechSoft is propelled by the belief that rapid and fascinating developments in the engineering, information technology, science and analytics can be applied to find ground breaking solutions in several key areas of banking and financial services. These solutions create competitive advantage & strengths through enhanced knowledge, better risk management and a clearer vision of the dynamics that rule the financial service business. Our business principles combine best of consulting capabilities to deliver high quality, high value and cost effective solutions that exceed client’s needs and expectation, keeping in mind long-term relationships.

We develop custom software together with our clients to solve their business requirements, building long-term relationships of trust. We approach the use of software tools based on artificial intelligence to improve the business processes of our clients. Incorporating custom built predictive models.

Neuraltronic is a technology company that uses cutting-edge Artificial Intelligence (AI) to solve business-specific needs. Our Vision is that applied AI is the future of humanity. So we took on the Mission of developing projects that facilitate the daily lives of businesses and people, fostering technological integration and increased efficiency. Neuraltronic's portfolio includes Computer Vision, Natural Language, Virtual Assistants, Autonomous Vehicles and Smart Robots. Our projects are tailor-made to the customer challenges, in that way we are able to close the gap between problems and solutions together. Our headquarters is in Rio de Janeiro, Brazil. There we employ a team experienced in various forms of hardware and software technologies

Neuraly is a clinical-stage company whose mission is to discover and develop scientific discoveries in neurology into revolutionary new drugs that can radically improve and prolong the lives of people suffering from the devastating consequences of diseases such as Parkinson’s disease (PD), Alzheimer’s disease (AD) and other neurodegenerative disorders. The company is leveraging a deep understanding of the role of glia biology in neuroinflammation and neuroprotection in advancing a risk-diversified product portfolio for PD and AD.

NeuraMetrix measures brain health using a digital bio-marker based on inconsistency of typing cadence. We developed NeuraMetrix TC (Typing Cadence) to monitor brain health without any tests or special equipment. Installed on a home computer, it captures typing cadence in milliseconds, allowing the detection of subtle changes in cognitive and motor function and calculation of a digital bio-marker. NeuraMetrix TC measures the "inconsistency"​ in typing cadence, a potential indication of onset and progression of neurodegenerative diseases. NeuraMetrix TC is sensitive enough to detect very early changes in cognitive and motor function and measure decline/progress over time. It is passive, independent of language, culture and education and does not require tests, sensors, gross motor skills or physician interaction. The Company completed its initial study with the Michael J. Fox Foundation's Fox Trial Finder. Researchers at leading academic institutions around the world are using NeuraMetrix TC in research programs involving ADHD, Brain Tumors, Chemo Brain, Depression, Epilepsy, Huntington's Disease, Multiple Sclerosis, Parkinson's Disease, REM Sleep Disorder and Traumatic Brain Injury. We are exploring research relationships in Alzheimer's Disease. NeuraMetrix is working with researchers at Parkinson’s Institute and Clinical Center, Philipps-Universität Marburg (Germany), University of Ulm (Germany), Karolinska Institute (Sweden), University of Iowa, Gladstone Institutes, UCSF, Michael J. Fox Foundation, Stanford University, Sogn and Fjordane University College (Norway), University of Toronto, New York University, Vanderbilt University and Washington University.

Neuranext specialises in the development of Artificial Intelligence (AI) for practical applications. AI, as applied today. In the past five years, AI has made some remarkable achievements. Objects can be accurately recognised in images randomly picked from the Internet, and human champions in games of skill and chance such as Go and Texas Hold Em poker have been beaten. Technologies thought impossible only a few years ago, such as automated driving, are now a reality. Impressive as these accomplishments are, they merely skim the surface of the number of challenges currently in need of solutions. Many real problems facing industry and society today remain to be solved and AI and machine learning can, in many instances, play a vital role. Yet figuring out how to apply them to any of these problems may seem daunting, even to the most dedicated professional. Neuranext Neuranext has the potential to assist. We start the AI journey by asking What do you want to achieve? This is step one in determining if AI can assist solve a specific problem. We then advise what may be done, which can include helping clients to frame the problem by assisting them to identify and define key metrics, variables and datasets. From there we commence a journey of research and development, culminating in a deployable system that will enhance outcomes for the specific task. Our scope Neuranexts Director, Chairman and co-founder, Dr Andrew Kyngdon, has the experience to work with clients on problems that involve making decisions of a high stakes nature. He has several years experience in high stakes situations involving large scale datasets. Neuranext believes that high stakes situations reinforce our underlying philosophy that we work to assist people to solve problems. After all, the most powerful Neural Network ever devised is the human brain. If you feel that you have a problem that you think AI or Machine Learning can help solve, please contact us.